Shylet Chengedza, Ph.D. - Publications

Affiliations: 
2009 University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Biochemistry, Oncology, Cell Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Chengedza S, Benbrook DM. NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis. Anti-Cancer Drugs. 21: 297-305. PMID 20032777 DOI: 10.1097/Cad.0B013E3283350E43  0.58
2010 Moxley KM, Chengedza S, Benbrook DM. Erratum to “Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents” [Gynecol. Oncol. 115 (2009) 438–442] Gynecologic Oncology. 117: 510. DOI: 10.1016/J.Ygyno.2010.02.026  0.542
2009 Moxley KM, Chengedza S, Benbrook DM. Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents. Gynecologic Oncology. 115: 438-42. PMID 19804900 DOI: 10.1016/J.Ygyno.2009.09.007  0.629
2009 Liu T, Masamha CP, Chengedza S, Berlin KD, Lightfoot S, He F, Benbrook DM. Development of flexible-heteroarotinoids for kidney cancer. Molecular Cancer Therapeutics. 8: 1227-38. PMID 19417155 DOI: 10.1158/1535-7163.Mct-08-1069  0.511
2009 Myers T, Chengedza S, Lightfoot S, Pan Y, Dedmond D, Cole L, Tang Y, Benbrook DM. Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo. Investigational New Drugs. 27: 304-18. PMID 18802666 DOI: 10.1007/S10637-008-9175-7  0.635
2008 Benbrook DM, Lightfoot S, Ranger-Moore J, Liu T, Chengedza S, Berry WL, Dozmorov I. Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. Gene Regulation and Systems Biology. 2: 21-42. PMID 19784388 DOI: 10.4137/Grsb.S344  0.549
Show low-probability matches.